DRKS00025069招募中3 期
Re-irradiation of recurrent Glioblastoma withCarbon-Ions (C12) versus Stereotactic Radiotherapy with Photons - A Multicenter, Prospective Randomized Two-Arm Trial - GIRO
适应症
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 入组人数
- 190
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized controlled study
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 69 Years（—）
- 性别
- All
入选标准
- •1. recurrent glioblastoma
- •2. Karnofsky index of =60%
- •3. 18 = age > 70 years
- •4. preceding radiotherapy at primary diagnosis
- •5. time after re-irradiation >6 months
- •6. written informed consent
排除标准
- •1. Gliomatosis cerebri
- •2. distant recurrence
- •3. involvement of Liquor cerebrospinalis
- •4. preceding re-radiotherapy of gliablastom
- •5. patient unable to give consent
- •6. pregnancy
- •7. decompensated concomitant disease of the respiratory organs, cardiovascular system, metabolism, hematopoietic system, coagulation or kidney function
- •8. concurrent participation in other clinical trials that may influence the results of this study
- •9. active medical implants without authorisation for ion irradiation at the time of treatment (e.g. pacemaker, defibrillator)
研究者
相似试验
已完成
不适用
Radiotherapy for glioblastoma: Dose escalation trial of IMRT after hyperbaric oxygen therapyGlioblastomaJPRN-UMIN000027623Tobata Kyoritsu Hospital18
进行中（未招募）
1 期
Study to evaluate the potentiation effect of radiotherapy by AGuIX nanoparticles for the treatment of persistent glioblastomaPersistent Glioblastoma Multiforme, grade IVMedDRA version: 20.0Level: PTClassification code 10018337Term: Glioblastoma multiformeSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2021-003774-32-ITDIPARTIMENTO BIOMEDICINA E PREVENZIONE UNIVERSITà DEGLI STUDI DI ROMA TOR VERGATA30
已完成
1 期
Dose Escalation Trial of Re-irradiation in Good Prognosis Recurrent GlioblastomaAstrocytoma, Grade IVGiant Cell GlioblastomaGliosarcomaGlioblastoma MultiformeNCT02709226National Cancer Institute (NCI)17
已完成
不适用
Investigation of response of glioblastomas to cytotoxic drugs in vitro (ivt Study)C71.9Brain, unspecifiedglioblastomaDRKS00000264niversitätsklinikumRheinisch-Westfälische Technische Hochschule Aachen24
进行中（未招募）
不适用
Traitement des récidives de glioblastomes par le SUTENT (SU11248) : essai de phase 2 avec étude translationnelle biologique et en imagerie - GLIRESPatients atteints de glioblastomes en récidiveMedDRA version: 8.1Level: PTClassification code 10018336Term: GlioblastomesEUCTR2008-005169-78-FRASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)